Effects of TRAP-1-Like Protein (TLP) Gene on Collagen Synthesis Induced by TGF-β/Smad Signaling in Human Dermal Fibroblasts

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Wang, Xue ^a   Qian, Yunliang ^a   Jin, Rong ^a   Wo, Yan ^a   Chen, Jun ^a   Wang, Chen ^a   Wang, Danru ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CYTOPLASM PROTEIN; LENTIVIRUS VECTOR; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRAP 1 LIKE PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL ASSAY; CELL VIABILITY; COLLAGEN SYNTHESIS; CONTROLLED STUDY; GENE THERAPY; GENETIC TRANSFECTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HYPERTROPHIC SCAR; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SCAR FORMATION; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; WESTERN BLOTTING; WOUND HEALING;

CICATRIX, HYPERTROPHIC; COLLAGEN; FIBROBLASTS; GENETIC VECTORS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LENTIVIRUS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKIN; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA; VESICULAR TRANSPORT PROTEINS; WOUND HEALING;

EID: 84873936717     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055899     Document Type: Article

References (36)

1. Wolfram D, Tzankov A, Pülzl P, Piza-Katzer H, (2009) Hypertrophic scars and keloids-a review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg 35: 171-181.
2. Leask A, Abraham DJ, (2004) TGF-beta signaling and the fibrotic response. FASEB J 18: 816-827.
3. Chin GS, Liu W, Peled Z, Lee TY, Steinbrech DS, et al. (2001) Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts. Plast Reconstr Surg 108: 423-429.
4. Huang JS, Wang YH, Ling TY, Chuang SS, Johnson FE, et al. (2002) Synthetic TGF-beta antagonist accelerates wound healing and reduces scarring. FASEB J 16: 1269-1270.
5. Singer AJ, Huang SS, Huang JS, McClain SA, Romanov A, et al. (2009) A novel TGF-beta antagonist speeds reepithelialization and reduces scarring of partial thickness porcine burns. J Burn Care Res 30: 329-334.
6. Wieser R, Wrana JL, Massagué J, (1995) GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex. EMBO J 14: 2199-2208.
7. Lan HY, (2008) Smad7 as a therapeutic agent for chronic kidney diseases. Front Biosci 13: 4984-4992.
8. Autio P, Oikarinen A, Melkko J, Risteli J, Risteli L, (1994) Systemic glucocorticoids decrease the synthesis of type I and type III collagen in human skin in vivo, whereas isotretinoin treatment has little effect. Br J Dermatol 131: 660-663.
9. Wurthner JU, Frank DB, Felici A, Green HM, Cao Z, et al. (2001) Transforming growth factor-beta receptor-associated protein 1 is a Smad4 chaperone. J Biol Chem 276: 19495-19502.
10. Felici A, Wurthner JU, Parks WT, Giam LR, Reiss M, et al. (2003) TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling. EMBO J 22: 4465-4477.
11. Sayah DN, Soo C, Shaw WW, Watson J, Messadi D, et al. (1999) Downregulation of apoptosis-related genes in keloid tissues. J Surg Res 87: 209-16.
12. Cheng B, Liu HW, Fu XB, Sheng ZY, Li JF, (2008) Coexistence and upregulation of three types of opioid receptors, mu, delta and kappa, in human hypertrophic scars. Br J Dermatol 158: 713-720.
13. Liu X, Li P, Liu P, Xiong R, Zhang E, et al. (2008) The essential role for c-Ski in mediating TGF-beta1-induced bi-directional effects on skin fibroblast proliferation through a feedback loop. Biochem J 409: 289-297.
14. Tan WQ, Gao ZJ, Xu JH, Yao HP, (2011) Inhibiting scar formation in vitro and in vivo by adenovirus-mediated mutant Smad4: a preliminary report. Exp Dermatol 20: 119-124.
15. Dooley A, Shi-Wen X, Aden N, Tranah T, Desai N, et al. (2010) Modulation of collagen type I, fibronectin and dermal fibroblast function and activity, in systemic sclerosis by the antioxidant epigallocatechin-3-gallate. Rheumatology (Oxford) 49: 2024-2036.
16. Li J, Chen J, Kirsner R, (2007) Pathophysiology of acute wound healing. Clin Dermatol 25: 9-18.
17. Werner S, Grose R, (2003) Regulation of wound healing by growth factors and cytokines. Physiol Rev 83: 835-870.
18. Armour A, Scott PG, Tredget EE, (2007) Cellular and molecular pathology of HTS: basis for treatment. Wound Repair Regen 15Suppl 1: S6-17.
19. Xu L, (2006) Regulation of Smad activities. Biochim Biophys Acta 1759: 503-513.
20. Verrecchia F, Mauviel A, (2007) Transforming growth factor-beta and fibrosis. World J Gastroenterol 13: 3056-3062.
21. Moustakas A, Souchelnytskyi S, Heldin CH, (2001) Smad regulation in TGF-beta signal transduction. J Cell Sci 114: 4359-4369.
22. Heldin CH, Miyazono K, ten Dijke P, (1997) TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390: 465-471.
23. Schiller M, Javelaud D, Mauviel A, (2004) TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing. J Dermatol Sci 35: 83-92.
24. Cui W, Jin HB, Li ZW, (2010) Mechanism of the transforming growth factor-beta induction of fibronectin expression in hepatic stem-like cells. Braz J Med Biol Res 43: 36-42.
25. Chen SJ, Yuan W, Mori Y, Levenson A, Trojanowska M, et al. (1999) Stimulation of type I collagen transcription in human skin fibroblasts by TGF-beta: involvement of Smad 3. J Invest Dermatol 112: 49-57.
26. Wang Z, Gao Z, Shi Y, Sun Y, Lin Z, et al. (2007) Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts. J Plast Reconstr Aesthet Surg 60: 1193-1199.
27. Uemura M, Swenson ES, Gaça MD, Giordano FJ, Reiss M, et al. (2005) Smad2 and Smad3 play different roles in rat hepatic stellate cell function and alpha-smooth muscle actin organization. Mol Biol Cell 16: 4214-4224.
28. Flanders KC, (2004) Smad3 as a mediator of the fibrotic response. Int J Exp Pathol 85: 47-64.
29. Piek E, Ju WJ, Heyer J, Escalante-Alcalde D, Stewart CL, et al. (2001) Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts. J Biol Chem 276: 19945-19953.
30. Bonniaud P, Kolb M, Galt T, Robertson J, Robbins C, et al. (2004) Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis. J Immunol 173: 2099-2108.
31. Zhu B, Wang YJ, Zhu CF, Lin Y, Zhu XL, et al. (2010) Triptolide inhibits extracellular matrix protein synthesis by suppressing the Smad2 but not the MAPK pathway in TGF-beta1-stimulated NRK-49F cells. Nephrol Dial Transplant 25: 3180-3191.
32. Lei B, Hitomi H, Mori T, Nagai Y, Deguchi K, et al. (2011) Effect of efonidipine on TGF-β1-induced cardiac fibrosis through Smad2-dependent pathway in rat cardiac fibroblasts. J Pharmacol Sci 117: 98-105.
33. Ghosh AK, (2002) Factors involved in the regulation of type I collagen gene expression: implication in fibrosis. Exp Biol Med (Maywood) 227: 301-314.
34. Caplan S, Hartnell LM, Aguilar RC, Naslavsky N, Bonifacino JS, (2001) Human Vam6p promotes lysosome clustering and fusion in vivo. J Cell Biol 154: 109-122.
35. Schonthaler HB, Fleisch VC, Biehlmaier O, Makhankov Y, Rinner O, et al. (2008) The zebrafish mutant lbk/vam6 resembles human multisystemic disorders caused by aberrant trafficking of endosomal vesicles. Development 135: 387-399.
36. Messler S, Kropp S, Episkopou V, Felici A, Würthner J, et al. (2011) The TGF-β signaling modulators TRAP1/TGFBRAP1 and VPS39/Vam6/TLP are essential for early embryonic development. Immunobiology 216: 343-350.